Related Experiment Videos
Quantitative structure activity relationships in drug metabolism
Kamaldeep K Chohan1, Stuart W Paine, Nigel J Waters
1Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, UK. Kamaldeep.Chohan@ astrazeneca.com
Current Topics in Medicinal Chemistry
|August 22, 2006
Summary
This review explores computational quantitative structure-activity relationship (QSAR) methods for predicting drug metabolism by Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes. Future research should focus on developing broader models for these and other key metabolizing enzymes.
Area of Science:
- Computational chemistry
- Pharmacology
- Drug metabolism
Background:
- Drug metabolism is crucial for determining drug efficacy and safety.
- Major drug-metabolizing enzymes include Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
- Understanding molecular features influencing enzyme interactions is key.
Purpose of the Study:
- To review contemporary computational quantitative structure-activity relationship (QSAR) approaches for modeling drug metabolism.
- To elucidate molecular features affecting compound binding and metabolism by CYP and UGT enzymes.
- To identify challenges and opportunities in QSAR for drug metabolism.
Main Methods:
- Review of 61 references on computational QSAR methods.
- Analysis of 2D and 3D QSAR, pharmacophore modeling, and nonlinear techniques.
- Application of techniques like recursive partitioning, neural networks, and support vector machines.
Main Results:
- Contemporary QSAR approaches are effectively modeling drug metabolism by CYP and UGT.
- These methods elucidate specific molecular features influencing enzyme binding and metabolic pathways.
- Nonlinear techniques and advanced QSAR models show promise in predicting metabolic outcomes.
Conclusions:
- Computational QSAR is a valuable tool for understanding and predicting drug metabolism.
- There is a need for 'global' models applicable across various CYP and UGT variants.
- Future research should extend QSAR applications to other significant drug-metabolizing enzymes.